VMD: Explanation for business result in Q4, 2013

Vimedimex Medi – Pharma Joint Stock Company explained business result in Q4/2013 compared to Q4/2012 as follows:

·         Profit before tax and profit after tax in Q4/2013 increased VND7.94 billion, equivalent 80.43% and VND4.8 billion, equivalent to 57.44% compared to the same period of 2012 respectively because:

·         Net revenue in Q4/2013 increased by 15.81% and cost of goods sold increased by 17.25% compared to Q4/2012.

·         Financial revenue in Q4/2013 increased by 38.95%, equivalent to VND8.2 billion while total expenses only increased by 0.33%, equivalent to VND0.8 billion compared to Q4/2012.

HOSE

>   SC5: Resolution on organizing the 2013 Annual General Meeting (18/02/2014)

>   HAI: Explanation for business result in Q1, 2014 (18/02/2014)

>   FPT: Revenue & profit in 2013 (18/02/2014)

>   HPG: Explanation for business result in Q4, 2013 (18/02/2014)

>   MCP: Explanation for business result in Q4, 2013 (18/02/2014)

>   PGC: Explanation for business result in Q4, 2013 (18/02/2014)

>   VCF: Link to the financial statements of Quarter 4/2013 (18/02/2014)

>   VIC: Announcement of changes in business license (18/02/2014)

>   VNC: Financial Statement Quarter 4/2013 (18/02/2014)

>   VNN: Financial Statement Quarter 4/2014 (holding company) (18/02/2014)